Professional Documents
Culture Documents
Chinese Patents Fulltext
Chinese Patents Fulltext
16/06/12 9:16 PM
HOME
325
Bluesheet Contents
File Description Subject Coverage Tips Dialog File Data
PDF version DIALINDEX/OneSearch Categories Contact Terms and Conditions Sample Record Basic Index Additional Indexes Limit Sort Rank Map Predefined Format Options Rates
Tips [top]
http://library.dialog.com/bluesheets/html/bl0325.html
Page 1 of 14
16/06/12 9:16 PM
USE FILE 325 to search English translations of the fulltext of Chinese patents. EXPAND LS= to review legal status events of a Chinese patent. USE MAP to save patent or application numbers for locating related patents in other files.
SELECT TOPIC; MAP AN TEMP
CREATE AN ALERT to monitor new Chinese patents for a particular technology or competitor. USE IDPAT to group together multiple publication levels for the same invention across files.
SELECT TOPIC; IDPAT
16/06/12 9:16 PM
Contact [top]
The Chinese Patents Fulltext Database is produced by Scipat Benelux NV. Questions about database content should be directed to: Dialog Knowledge Center 2250 Perimeter Park Drive Suite 300 Morrisville, NC 27560 USA Telephone: 919-804-6400 800 Line: 1-800-3DIALOG Fax: 919-804-6410 E-Mail: customer@dialog.com
http://library.dialog.com/bluesheets/html/bl0325.html Page 3 of 14
16/06/12 9:16 PM
SciPat Benelux NV Zwolsestraat 17B-E 2587 TX Sheveningen, Netherlands Telephone: +31(0)70-306-7240 Fax: +31(0)70-306-7249
PA=,CO=,PL= Patent Assignee (name, country): SOLVAY PHARM BV, NL AU=, IV=, IL= Inventor (name, country): CORNELIS BAKKER, NL Patent Publications: Patent Number Kind PC=,PN=,PD=,AC=,AN=,AD= Main Patent: AC=,AN=,AD=,PR= Priority: CN 1639156 EP 2001200610
Date A
International Patent Classification: IPC Class Level Scope Position Status Version Date Action Date Source Office C07D-413/12 Main "Version 7" A61K-031/538;A61P-025/18 Secondary "Version 7" IC=,ICA=,ICC=,IA= International Patent Classification (Version 8): A61K-0031/5375 C I L R 20060101 20051220 M JP A61P-0043/00 C I L R 20060101 20051220 M JP C07D-0413/00 C I R 20060101 20051008 M EP A61P-0025/00 C I R 20060101 20060521 M WO IC= A61K-0031/538 A C07D-0413/12 A A61P-0043/00 A A61P-0025/18 A I I I I R L R L R 20060101 20051220 20060101 20051008 M R 20060101 20051220 20060101 20060521 M M EP M WO JP JP
http://library.dialog.com/bluesheets/html/bl0325.html
Page 4 of 14
16/06/12 9:16 PM
II I
LL L
MM M
JP JP JP
RT= Record Type (Availability): ABSTRACT SPECIFICATION CLAIMS IMAGE WD= Word Count: 747 LA= Publication Language: CHINESE LT= Translation Language: Human Assisted Machine Translation to English /AB Abstract: The invention claims a compound of formula i phenyl piperazine derivatives of methanesulfonic acid salt. The salt and the compound of the free base forms compared with the beneficial properties.
LS=, LD=,LM=,LY=
Legal Status Information (Event Date, Event, Details): 20061115 granted; Effective Date: N/A 20050907 initiative for examination as to substance/operation of substantive examination; Effective Date: N/A 20050713 publication; Effective Date: N/A
/SP,/TX Detailed Description: To dopamine d2 receptors and serotonin reuptake site with high affinity 8***4 reproducing 3 5 fluorine for 1h indol-3-yl propyl ! 1 piperazine base ! 2methyl for 2h 1 4 benzoxazine 3-ketone-2 methanesulfonic acid salt The invention claims a novel phenyl piperazine derivatives: Patent application number pct or ep 00/08090 not published claims a group of novel phenyl piperazine derivatives Material. Group the compound so as to dopamine d Receptor and serotonin reuptake position display of high hydrophilic And force. Such a combination for treating schizophrenia and other mental diseases is used for Can be completely curing diseases such as the characteristic of the positive end of the negative model shape. The compound displays dopamine d Receptor antagonist activity they potential Of inhibiting apomorphine the mouse body is caused by climbing the. The compound also display inhibiting And serotonin reuptake of active they reinforcing 5 htp the mouse body is induced
http://library.dialog.com/bluesheets/html/bl0325.html Page 5 of 14
16/06/12 9:16 PM
The action of. Such compounds in these to the clinic is suitable for anti-psychopathy medicine such as to avoid condition Reaction; Behav bradford van der heyden and brain res 1988 31: 61-67 the antidepressant anti-anxiety agent or agent such as preventing the pressure caused by sound; Van der Device poel and psychopharmacology 1989 97: 147-148 sensitive treating model is set with Active. And clinical is applied to the resistance dopamine d Receptor antagonists compared with the compound has Is low the orientation of the induced on the gear type animal on the body of the strong direct of syncope and it can be relaxed than current Memory anti-psychopathy medicine inducing small taper body outer side effect of. The compound has a pair of serotonin reuptake of inhibiting activity can be the The antidepressant anti-anxiety agent or agent sensitive action mode has the effect of the reason. The compound can be used to treat because of energy saving system of dopamine and serotonin energy system is Disorder caused by the central nervous system disease or disorder such as anxiety aggressive autism Vertigo depression cognitive or memory obstacle parkinson disease and it is especially schizophrenia and other Mental disease. In the formula methyl sulfonic acid salt and its free alkali is such as possible 99202710.2 between Second 89# compound especially has good property of. The methanesulfonic acid salt compound than the free alkali condition is easy to dissolve in water so it has good growth Material utilization rate. The compound having a chiral center; Its racemic mixture and single enantiomer are The invention belongs to the field of. The compound can be used when the liquid or solid carrier material such as auxiliary substance and is suitable for When made through the method of it is suitable for the medicine in the form of. The compound the dissociative alkali can be counted according to the ep 99202710.2 in the invention claims method for preparing. Free alkali according to known salt forming method of converted into methyl sulfonic acid salts. The invention can use the following to an embodiment example of invention is used for lifting. To 2.0 milligram g 4.7 mol of free alkali is used to the method in the ep 99202710.2
http://library.dialog.com/bluesheets/html/bl0325.html Page 6 of 14
16/06/12 9:16 PM
Preparation method of second 89# compound suspended in 40 ml of the methyl alcohol. The suspension is heated To 60 centigrade to about 2 minutes in adding 0.45 g 4.7 to mol methanesulfonic acid solution in 10 ml Methanol solution in the. Can be obtained through a clear solution. At 60 centigrade whisking for 5 minutes after starting crystallizing. The solution at 60 minutes in the cooling slowly to 20 centigrade at the temperature stir for 30min. Further at 60 minutes is cooled to 0 degree centigrade and stirring for 90 minutes. The obtained solid material by And filtering method is to separate and 5 millimeters the methanol washing and the pressure reducing 50 centigrade drying a Man. Can be obtained white methanesulfonic acid salt production efficiency is 88 % 2.17 g. Claims: /CM,/TX 1. The following formula 1 compound: 2. treating central nervous system diseases a pharmaceutical composition wherein it comprises to claim 1 the compound as active ingredient. 3. treating central nervous system disease and method wherein using to claim 1 the compound.
FIELD NAME All Basic Index Fields1,2 Abstract1,2 All Claims1,2 Specification1,2 Title 1,2 All Text1,2
INDEXING Segment & Word Segment & Word Segment & Word Segment & Word Segment & Word Segment & Word
SELECT EXAMPLES S METHANE(W)SULFON? S SEROTONIN(W)REUPTAKE S PIPERAZINE(W)DERIVATIVE?/AB S SALT/AB S CENTRAL(W)NERVOUS(W)SYSTEM?/CM S TREAT?/CM S BENZO(W)OXAZINE/SP S ANTI(W)ANXIETY/SP S DOPAMINE(W)D2/TI S PROPYL/TI S RECEPTOR(W)ANTAGONIST?/TX S METHYL/TX
None AB CM SP TI TX
fields for the file through 2007 are created by means of optical scanning of printed text. Human-assted machine translation (MAT) has been used to produce equivalent English text. Chinese characters that were scanned inocrrectly or could not be translated are represented in the text by the 3 asterisks (***).
2 All
chemical names are indexed as complete individual words and chemically significant word segments. Words
Page 7 of 14
http://library.dialog.com/bluesheets/html/bl0325.html
16/06/12 9:16 PM
such as CHLOROBENZENE can be retrieved by either segment, e.g., S CHLORO or S BENZENE. Any term in the Basic Index can be restricted to a full word using the /FW suffix, e.g., S BENZENE/FW. Locants, such as 2,3, indicate the position of a chemical group within the structure and are searched as words, e.g., S 2(W)3. Truncation of chemical segments is not recommended.
IC=
IC
Phrase
IC IC IL IM IV
Advanced International Patent Class (IPCR/8)9,10 Core International Patent Class (IPCR/8)9,10 Inventor Location Image16
http://library.dialog.com/bluesheets/html/bl0325.html
16/06/12 9:16 PM
LA LD LM LS LT LY NC NS PA
Inventor6 of Publication Language Legal Status Event Date11 Legal Status Event Month11 Legal Status11 Language of Translation Legal Status Event Year11 Number of Claims Number of Legal Status Events Patent Applicant/Assignee
Phrase Phrase Phrase Phrase Phrase Phrase Numeric Numeric Word & Phrase Phrase Phrase Phrase Phrase Phrase Phrase Phrase Phrase Phrase Phrase Numeric
S LA=CHINESE S LD=20061115 S LM=200611 S LS=INITIATIVE FOR EXAMINATION? S LA=ENGLISH S LY=2006 S NC=3 S NS=3 S PA= (SOLVAY(W)PHARM?) S PA=SOLVAY PHARM BV S PC=CN S PC=CN A S PC=WO A1 S PD=20050713 S PL=NL S PM=200507 S PN=WO 2006075416 S PN=CN 1639156 S PR=EP 2001200610 S PR=20010221 S PY=2005 S RT=IMAGE S RTABSTRACT S UD=9999 S WD=747 S WD<1000
PC= PD= None PL= PM= PN= PN= PR= PY= RT= UD= WD=
3 Use
PC PD PI PL PD PN PN PR PY None None WD
Patent Country Publication Date Patent Information12 Patent Assignee Location7 Publication Month PCT Publication Number13 Patent Number Priority Data Publication Year Record Type (Availability)14 Update Word Count15
the qualifier /PR to restrict a search to priority application data. Priority application numbers in source format and priority dates can also be searched in the Priority Application field PR=.
4 Priority
application numbers are formatted in standard DIALOG format for ease in MAPping to other patent databases. Annual series numbers contain 4 leading year digits, Use MAP PN or MAP AN to search for the corresponding records in other patent databases.
5 U.S.
priority application numbers may be searched in several ways: with four leading year digits, e.g., S AN=US 2000102574, with four trailing year digits, e.g., S AN=US 590668-1996, or with leading series digits, e.g., AN=US 60-85997.
6 Inventor
names may appear in direct order with the surname last or in inverted order with the surname first. For the most comprehensive retrieval, use the (N) operator, e.g. S AU=(ARNAUD(1N)BOURGE).
7 Inventor 8 Use
/MA to restrict International Patent Classification entries prior to 2006 to the main class to which a patent is
Page 9 of 14
http://library.dialog.com/bluesheets/html/bl0325.html
16/06/12 9:16 PM
the introduction of the Reformed International Patent Classification (IPCR/8) on January 1, 2006, the format of the IPC group has increased in length from 3 to 4 digits. For comprehensive retrieval, both forms of the classification should be searched, e.g., S IC=H04R-025/00 OR IC=H04R-0025/00 . IPCR/8 classifications can also be searched in the ICA= (Advanced) and ICC= (Core) indexes.
10 Each
IPCR/8 classification code is also assigned a series of attributes which include classification level (A Advanced, C - Core), value (I - Inventive, N - Non-inventive), position (F - First, L - Later), status (B - basic, R Reclassified, V - Various, D - Deleted), version date, action date, source (H - Human, M - Machine, G - Generated), and assigning office. The IPC attributes can be searched with the IA= prefix and can be linked to an IPCR/8 classification code using the S operator and quotes around the classification code, e.g., S IA=F(S)IC="A61K0031/198" .
11 Legal
Status events are provided for most records. Information includes the event date (LD=) and the event description( LS=). A complete list of legal status event can be found in the LS= index.
12 The
patent information display consists of patent and application data, and priority data. Starting in January 2008, it also includes "based on" information for WO patents and applications to which the Chinese patent is related.
13 From
2008 forward, PCT publications and applications on which Chinese patents are based can be searched using the corresponding number and date fields.
14 Record
Type (RT=) can be used to identify records that contain images, abstracts, legal status, specifications or claims. The limit /FULLTEXT can be used to restrict a search to records that include a specification and claims.
15 Word
Count applies only to the text fields, i.e., specification and claims. WD= may be used to search the word count in either German or English text as well as the combined text.
16 A
search can be restricted to patents containing a clipped image, if available, by including RT=IMAGE in the strategy.
LIMIT [top]
SUFFIX /FULLTEXT /YYYY FIELD NAME Records containing Full Text Publication Year EXAMPLES S S1/FULLTEXT S S4/2001
SORT [top]
SORTABLE FIELDS , AA, AN, AU, PA, PD, PN, TI EXAMPLES SORT S6/ALL/AU
RANK [top]
RANK FIELDS
http://library.dialog.com/bluesheets/html/bl0325.html
EXAMPLES
Page 10 of 14
16/06/12 9:16 PM
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Additional RANK codes include: ANPR (Priority Application Number; ICMA (Main International Patent Class prior to 2006).
RANK AC
MAP [top]
MAP FIELDS AA, AN, ANPR, AU, CO, CT, CTPN, IC, PA, PN, PNCT, PNMP EXAMPLES MAP PN T
http://library.dialog.com/bluesheets/html/bl0325.html
Page 11 of 14
16/06/12 9:16 PM
17 Images
or PDFs can be displayed when searches are conducted using DialogLink 5, DialogClassic on the Web, or DialogWeb. Images are provided in formats 12, 13, 15, 17, and 19, and can also be included in other formats by specifying the display tag IM. Remote links to PDFs of the original Chinese patent document display with formats 3,9,12,13,15,17,19.
Rates [top]
Rates For File: Chinese Patents Fulltext[325] Cost per DialUnit: $5.97 Cost per minute: $3.15 Report Elements $0.00 Rank Elements $0.00 ALERT (default) $9.00 ALERT (Monthly) * $24.00 ALERT (Biweekly/twice a month) * $14.00 ALERT (Weekly) $8.75 ALERT (Daily) * $8.75 ALERT (Calendar weekly) * $8.75 ALERT (Intraday) * $8.75 * = custom scheduled Alerts only ALERT Number of included prints 0 Format 1 2 3 5 6 7 8 9 12 13 15 17 19 26 49 69 KWIC95 KWIC96 Types $0.00 $4.00 $2.25 $7.00 $0.32 $8.00 $0.64 $9.25 $4.50 $2.75 $7.50 $8.50 $10.00 $0.32 $10.00 $0.75 $0.00 $0.00 Prints $0.00 $4.00 $2.25 $7.00 $0.32 $8.00 $0.75 $9.25 $4.50 $2.75 $7.50 $8.50 $10.00 $0.32 $10.00 $0.75 NA NA
REDIST/COPY Multiplier Table: Range 1-2 3-25 26-100 101-200 201-500 501-1000 Multiplier 1.00 1.50 3.00 4.00 6.00 8.00
Page 12 of 14
http://library.dialog.com/bluesheets/html/bl0325.html
16/06/12 9:16 PM
1001 or more
10.00
ARCHIVE Multiplier Table: Range 1-25 26-200 201-500 501-1000 1001 or more Multiplier 1.50 3.00 6.00 8.00 10.00
[top]
http://library.dialog.com/bluesheets/html/bl0325.html
Page 13 of 14
16/06/12 9:16 PM
http://library.dialog.com/bluesheets/html/bl0325.html
Page 14 of 14